KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Equity: 2009-2024

Historic Return on Equity for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -0.29%.

  • Teva Pharmaceutical Industries' Return on Equity rose 49.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 49.00%. This contributed to the annual value of -0.29% for FY2024, which is 22.00% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Return on Equity stood at -0.29% for FY2024, which was down 293.35% from -0.07% recorded in FY2023.
  • Teva Pharmaceutical Industries' Return on Equity's 5-year high stood at 0.04% during FY2021, with a 5-year trough of -0.32% in FY2020.
  • In the last 3 years, Teva Pharmaceutical Industries' Return on Equity had a median value of -0.25% in 2022 and averaged -0.21%.
  • Its Return on Equity has fluctuated over the past 5 years, first spiked by 36bps in 2021, then decreased by 29bps in 2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' Return on Equity (Yearly) stood at -0.32% in 2020, then skyrocketed by 36bps to 0.04% in 2021, then declined by 29bps to -0.25% in 2022, then climbed by 18bps to -0.07% in 2023, then fell by 22bps to -0.29% in 2024.